BioSpace News Archive

Novel Brain Scan Diagnoses Alzheimer’s and Progression with Impressive Accuracy

Researchers at Imperial College London have developed a novel diagnosis method with a high rate of correct Alzheimer’s diagnosis and the ability to determine the patient’s progression stage.

June 21, 2022
·
3 min read
·
Jazmine Colatriano M.S.
Policy

PTC Ready to Take Another Shot at FDA Approval of DMD Drug, Translarna

For years, PTC Therapeutics has attempted to win regulatory approval for its DMD drug, Translarna. Now, the company believes it has data that will support another filing for FDA approval.

June 21, 2022
·
3 min read
·
Alex Keown
Business

Mark Cuban’s Pharmacy Touts “Safe, Affordable Medicines”

Mark Cuban Cost Plus Drug Company now boasts over 700 prescription generic drugs for a variety of conditions, ranging from acid reflux to dementia to autoimmune diseases like Rheumatoid Arthritis.

June 21, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Diversity Makes Clinical Trial Recruitment Easier and Outcomes Better

Decentralized clinical trials may cost more upfront, but can have huge returns on the back end, according to speakers at Informa Connect’s Decentralized Clinical Trials meeting.

June 21, 2022
·
5 min read
·
Gail Dutton
CRISPR Therapeutics Eyes Historic First in Gene Therapy

CRISPR Therapeutics could be on the cusp of achieving a first in gene therapy, the first company to achieve regulatory approval for a CRISPR-Cas9 program.

June 21, 2022
·
3 min read
·
Alex Keown
Policy

FDA, HHS Sued by Doctors Over Controversial Drug Ivermectin

Three physicians filed a lawsuit against the FDA alleging the organization acted outside its authority and with their ability to practice medicine by discouraging the use of ivermectin to treat COVID-19.

June 21, 2022
·
5 min read
·
Mark Terry
Policy

Retracted Studies Continue to Spur Funding for Cardiac Stem Cell Research

Despite the refutation of research articles by Piero Anversa, they continue to serve as a basis for funding requests from scientists who hope to prove that the heart can regenerate cardiac muscle.

June 21, 2022
·
2 min read
·
Alex Keown
Drug Development

Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development

The week began with positive updates in the vaccine development space against various infectious diseases from Emergent, Merck, Affinivax and Ocugen.

June 21, 2022
·
3 min read
·
Vanessa Doctor, RN
Drug Development

Disappointing Results End 9 Meters’ Phase III Trial for Celiac Treatment

9 Meters Biopharma is discontinuing a Phase III clinical trial for larazotide, a treatment for celiac disease as interim results were not statistically significant.

June 21, 2022
·
3 min read
·
Hannah Chudleigh
Drug Development

TC BioPharm’s Co-Stimulatory CAR Therapy May Be Safer and More Economical

TC BioPharm is developing a new approach to chimeric antibody receptor (CAR) T-cell therapies with the potential to eliminate off-target effects, and possibly help more patients.

June 21, 2022
·
5 min read
·
Gail Dutton